Laura Esserman, MD, MBA
Dr. Laura Esserman is a professor of surgery and radiology at UCSF and director of the UCSF Carol Franc Buck Breast Care Center. Dr. Esserman is an internationally recognized breast surgeon and visionary in personalized medicine. Her breast cancer work spans the spectrum from basic science to public policy issues and the impact of both on clinical care delivery. She is a leader in the I-SPY trial, a groundbreaking collaboration of the National Cancer Institute, FDA, over 20 cancer research centers, and major pharmaceutical companies. This is now an international model for translational research.
In addition, she led the creation of the UC-wide Athena Breast Health Network, a system designed to integrate clinical care and research by following 150,000 women from screening through treatment and outcomes. She spearheads the WISDOM study to improve breast cancer screening by testing and comparing annual screening against a personalized screening strategy informed by each woman’s individual risk.
Dr. Esserman has published more than 270 articles in peer-reviewed journals. She was featured as one of TIME’s 100 Most Influential People of 2016 and was the recipient of the 2016 Stanford Business School Arbuckle Award and the 2016 Personalized Medicine World Conference Pioneer and Luminary Award.